• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
An unusual phenotype of hereditary AApoAI amyloidosis caused by a novel Asp20Tyr substitution is linked to pH-dependent aggregation of apolipoprotein A-I.由新型Asp20Tyr替代引起的遗传性载脂蛋白AI淀粉样变性的一种不寻常表型与载脂蛋白A-I的pH依赖性聚集有关。
Biochim Biophys Acta Mol Basis Dis. 2025 Jun;1871(5):167820. doi: 10.1016/j.bbadis.2025.167820. Epub 2025 Mar 29.
2
Amyloidogenic mutations in human apolipoprotein A-I are not necessarily destabilizing - a common mechanism of apolipoprotein A-I misfolding in familial amyloidosis and atherosclerosis.载脂蛋白 A-I 中的淀粉样生成突变不一定会使其不稳定——家族性淀粉样变性和动脉粥样硬化中载脂蛋白 A-I 错误折叠的常见机制。
FEBS J. 2014 Jun;281(11):2525-42. doi: 10.1111/febs.12809. Epub 2014 Apr 28.
3
The crystal structure of the C-terminal truncated apolipoprotein A-I sheds new light on amyloid formation by the N-terminal fragment.载脂蛋白 A-I C 端截短体的晶体结构为 N 端片段形成淀粉样纤维提供了新的视角。
Biochemistry. 2012 Jan 10;51(1):10-8. doi: 10.1021/bi2017014. Epub 2011 Dec 29.
4
Hereditary apolipoprotein AI-associated amyloidosis in surgical pathology specimens: identification of three novel mutations in the APOA1 gene.手术病理标本中的遗传性载脂蛋白AI相关淀粉样变性:APOA1基因三个新突变的鉴定
J Mol Diagn. 2009 May;11(3):257-62. doi: 10.2353/jmoldx.2009.080161. Epub 2009 Mar 26.
5
Cell milieu significantly affects the fate of AApoAI amyloidogenic variants: predestination or serendipity?细胞微环境对 AApoAI 淀粉样变变体的命运有显著影响:是命中注定还是机缘巧合?
Biochim Biophys Acta Gen Subj. 2018 Mar;1862(3):377-384. doi: 10.1016/j.bbagen.2017.11.018. Epub 2017 Nov 23.
6
Dual role of an N-terminal amyloidogenic mutation in apolipoprotein A-I: destabilization of helix bundle and enhancement of fibril formation.载脂蛋白 A-I N 端淀粉样纤维形成突变的双重作用:螺旋束的不稳定性和纤维形成的增强。
J Biol Chem. 2013 Jan 25;288(4):2848-56. doi: 10.1074/jbc.M112.428052. Epub 2012 Dec 11.
7
Chameleon 'aggregation-prone' segments of apoA-I: A model of amyloid fibrils formed in apoA-I amyloidosis.载脂蛋白A-I的变色龙“易于聚集”片段:载脂蛋白A-I淀粉样变性中形成的淀粉样纤维模型。
Int J Biol Macromol. 2015 Aug;79:711-8. doi: 10.1016/j.ijbiomac.2015.05.032. Epub 2015 Jun 3.
8
Effects of Disease-Causing Mutations on the Conformation of Human Apolipoprotein A-I in Model Lipoproteins.致病突变对模型脂蛋白中人类载脂蛋白A-I构象的影响。
Biochemistry. 2018 Jul 31;57(30):4583-4596. doi: 10.1021/acs.biochem.8b00538. Epub 2018 Jul 13.
9
Molecular Insights into Human Hereditary Apolipoprotein A-I Amyloidosis Caused by the Glu34Lys Mutation.由Glu34Lys突变引起的人类遗传性载脂蛋白A-I淀粉样变性的分子见解
Biochemistry. 2018 Oct 2;57(39):5738-5747. doi: 10.1021/acs.biochem.8b00817. Epub 2018 Sep 19.
10
Structural Stability and Local Dynamics in Disease-Causing Mutants of Human Apolipoprotein A-I: What Makes the Protein Amyloidogenic?人类载脂蛋白A-I致病突变体的结构稳定性与局部动力学:是什么使该蛋白具有淀粉样变性倾向?
J Mol Biol. 2016 Jan 29;428(2 Pt B):449-62. doi: 10.1016/j.jmb.2015.10.029. Epub 2015 Nov 10.

引用本文的文献

1
Structural variability of apolipoprotein A-I amyloid fibrils across organs, mutations, and clinical presentations, revealed by cryo-EM.通过冷冻电镜揭示的载脂蛋白A-I淀粉样原纤维在不同器官、突变和临床表现中的结构变异性。
bioRxiv. 2025 Jul 11:2025.07.08.663734. doi: 10.1101/2025.07.08.663734.

本文引用的文献

1
Distinct roles of size-defined HDL subpopulations in cardiovascular disease.大小明确的高密度脂蛋白亚群在心血管疾病中的不同作用。
Curr Opin Lipidol. 2025 Jun 1;36(3):111-118. doi: 10.1097/MOL.0000000000000959. Epub 2024 Oct 25.
2
Amyloid nomenclature 2024: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee.淀粉样变命名 2024:更新、新蛋白及国际淀粉样变学会(ISA)命名委员会的建议。
Amyloid. 2024 Dec;31(4):249-256. doi: 10.1080/13506129.2024.2405948. Epub 2024 Sep 30.
3
Apolipoprotein A-I: Potential Protection Against Intestinal Injury Induced by Dietary Lipid.载脂蛋白A-I:对膳食脂质诱导的肠道损伤的潜在保护作用。
J Inflamm Res. 2024 Aug 28;17:5711-5721. doi: 10.2147/JIR.S468842. eCollection 2024.
4
Anti-inflammatory mechanism of Apolipoprotein A-I.载脂蛋白 A-I 的抗炎机制。
Front Immunol. 2024 Jul 8;15:1417270. doi: 10.3389/fimmu.2024.1417270. eCollection 2024.
5
Flipped C-Terminal Ends of APOA1 Promote ABCA1-Dependent Cholesterol Efflux by Small HDLs.载脂蛋白 A1 C 端翻转促进小高密度脂蛋白依赖 ABCA1 的胆固醇外流。
Circulation. 2024 Mar 5;149(10):774-787. doi: 10.1161/CIRCULATIONAHA.123.065959. Epub 2023 Nov 29.
6
Molecular modeling of apoE in complexes with Alzheimer's amyloid-β fibrils from human brain suggests a structural basis for apolipoprotein co-deposition with amyloids.apoE 与人脑阿尔茨海默病淀粉样β纤维复合物的分子建模表明载脂蛋白与淀粉样蛋白共沉积的结构基础。
Cell Mol Life Sci. 2023 Nov 27;80(12):376. doi: 10.1007/s00018-023-05026-w.
7
Rare Forms of Cardiac Amyloidosis: Diagnostic Clues and Phenotype in Apo AI and AIV Amyloidosis.罕见类型的心脏淀粉样变性:载脂蛋白 AI 和 AIV 淀粉样变性的诊断线索和表型。
Circ Cardiovasc Imaging. 2023 Jul;16(7):523-535. doi: 10.1161/CIRCIMAGING.123.015259. Epub 2023 Jul 11.
8
Gastrointestinal amyloidosis: an often unexpected finding with systemic implications.胃肠道淀粉样变性:具有全身影响的一种常被漏诊的疾病。
Hum Pathol. 2023 Sep;139:27-36. doi: 10.1016/j.humpath.2023.06.007. Epub 2023 Jun 28.
9
Lipid-apolipoprotein interactions in amyloid fibril formation and relevance to atherosclerosis.脂质-载脂蛋白相互作用在淀粉样纤维形成中的作用及其与动脉粥样硬化的相关性。
Biochim Biophys Acta Proteins Proteom. 2019 May;1867(5):502-507. doi: 10.1016/j.bbapap.2018.08.010. Epub 2018 Sep 1.
10
A novel substitution of proline (P32L) destabilises β2-microglobulin inducing hereditary systemic amyloidosis.一种新型脯氨酸(P32L)取代导致β2-微球蛋白不稳定,引发遗传性系统性淀粉样变性。
Amyloid. 2022 Dec;29(4):255-262. doi: 10.1080/13506129.2022.2072199. Epub 2022 May 14.

由新型Asp20Tyr替代引起的遗传性载脂蛋白AI淀粉样变性的一种不寻常表型与载脂蛋白A-I的pH依赖性聚集有关。

An unusual phenotype of hereditary AApoAI amyloidosis caused by a novel Asp20Tyr substitution is linked to pH-dependent aggregation of apolipoprotein A-I.

作者信息

Prokaeva Tatiana, Jayaraman Shobini, Klimtchuk Elena, Burke Natasha, Spencer Brian, Nedelkov Dobrin, Chen Hui, Dasari Surendra, McPhail Ellen D, Pereira Lucas, Payne Michael C, Wong Sherry, Burks Eric J, Sanchorawala Vaishali, Gursky Olga

机构信息

Amyloidosis Center, Chobanian & Avedisian School of Medicine, Boston University, Boston, MA, USA.

Department of Pharmacology, Physiology & Biophysics, Chobanian & Avedisian School of Medicine, Boston University, Boston, MA, USA.

出版信息

Biochim Biophys Acta Mol Basis Dis. 2025 Jun;1871(5):167820. doi: 10.1016/j.bbadis.2025.167820. Epub 2025 Mar 29.

DOI:10.1016/j.bbadis.2025.167820
PMID:40164396
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11998993/
Abstract

Apolipoprotein A-I (apoA-I) plays beneficial roles as the major structural and functional protein on plasma high-density lipoproteins (HDL). However, APOA1 gene mutations can cause protein misfolding and pathologic amyloid deposition in various organs in human hereditary AApoAI amyloidosis, a potentially lethal systemic disease. We report esophageal and duodenal AApoAI amyloidosis in a 56-year-old patient with Barrett's esophagus, a condition involving chronic acid reflux. Amyloid deposits contained full-length apoA-I featuring a novel D20Y mutation identified by gene sequencing and protein mass spectrometry. Genetic analysis of asymptomatic family members revealed autosomal dominant inheritance. Fibril formation by the full-length variant apoA-I rather than its fragments and the location of the mutation in a conserved amyloid-prone N-terminal segment were highly unusual for hereditary AApoA-I amyloidosis. Structural and stability studies of the recombinant D20Y and wild-type apoA-I showed small but significant mutation-induced structural perturbations in the native lipid-free protein at pH 7.4. Major destabilization and aggregation of the variant protein were observed at pH 4.0. We propose that acidic conditions in Barrett's esophagus promoted protein misfolding and amyloid formation by the D20Y variant. These findings expand our understanding of the clinical features and molecular basis of AApoAI amyloidosis and suggest clinical strategies.

摘要

载脂蛋白A-I(apoA-I)作为血浆高密度脂蛋白(HDL)上的主要结构和功能蛋白发挥着有益作用。然而,在人类遗传性AApoAI淀粉样变性(一种潜在致命的全身性疾病)中,APOA1基因突变可导致蛋白质错误折叠和在各个器官中出现病理性淀粉样沉积。我们报告了一名患有巴雷特食管(一种涉及慢性胃酸反流的病症)的56岁患者出现食管和十二指肠AApoAI淀粉样变性。淀粉样沉积物含有全长apoA-I,通过基因测序和蛋白质质谱鉴定出一种新的D20Y突变。对无症状家庭成员的基因分析显示为常染色体显性遗传。全长变体apoA-I而非其片段形成原纤维以及该突变位于保守的易于形成淀粉样的N端区域,这在遗传性AApoA-I淀粉样变性中非常罕见。重组D20Y和野生型apoA-I的结构和稳定性研究表明,在pH 7.4时,无脂质天然蛋白中存在微小但显著的突变诱导结构扰动。在pH 4.0时观察到变体蛋白的主要去稳定化和聚集。我们提出,巴雷特食管中的酸性条件促进了D20Y变体的蛋白质错误折叠和淀粉样形成。这些发现扩展了我们对AApoAI淀粉样变性临床特征和分子基础的理解,并提出了临床策略。